PGIM Jennison Health Sciences Fund - Class A (PHLAX)
Fund Assets | 1.68B |
Expense Ratio | 1.13% |
Min. Investment | $1,000 |
Turnover | n/a |
Dividend (ttm) | 5.31 |
Dividend Yield | 15.50% |
Dividend Growth | 177.71% |
Payout Frequency | Annual |
Ex-Dividend Date | Dec 20, 2024 |
Previous Close | 34.29 |
YTD Return | -4.59% |
1-Year Return | 1.44% |
5-Year Return | 49.27% |
52-Week Low | 29.55 |
52-Week High | 43.93 |
Beta (5Y) | n/a |
Holdings | 45 |
Inception Date | Jun 30, 1999 |
About PHLAX
The Fund's investment strategy focuses on Health/Biotech with 1.14% total expense ratio. The minimum amount to invest in Prudential Sector Funds, Inc: PGIM Jennison Health Sciences Fund; Class A Shares is $1,000 on a standard taxable account. Prudential Sector Funds, Inc: PGIM Jennison Health Sciences Fund; Class A Shares seeks long-term capital appreciation. PHLAX invests primarily in equity-related securities of U.S. firms engaged in the following industries: hospitals, nursing and residential care, health and medical insurance carriers, pharmaceutical and medicine companies, and medical equipment firms.
Performance
PHLAX had a total return of 1.44% in the past year, including dividends. Since the fund's inception, the average annual return has been 13.67%.
Top 10 Holdings
57.84% of assetsName | Symbol | Weight |
---|---|---|
Eli Lilly and Company | LLY | 14.60% |
Prudential Govt Money Mkt Fd | n/a | 10.96% |
Vertex Pharmaceuticals Incorporated | VRTX | 4.95% |
argenx SE | ARGX | 4.85% |
Neurocrine Biosciences, Inc. | NBIX | 4.78% |
AstraZeneca PLC | AZN | 4.64% |
Thermo Fisher Scientific Inc. | TMO | 3.58% |
Novo Nordisk A/S | NVO | 3.50% |
Alnylam Pharmaceuticals, Inc. | ALNY | 3.15% |
UnitedHealth Group Incorporated | UNH | 2.85% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 20, 2024 | $5.31325 | Dec 20, 2024 |
Dec 20, 2023 | $1.91322 | Dec 20, 2023 |
Dec 20, 2022 | $0.61624 | Dec 20, 2022 |
Dec 20, 2021 | $14.02528 | Dec 20, 2021 |
Dec 20, 2019 | $1.43164 | Dec 20, 2019 |
Dec 20, 2018 | $4.77761 | Dec 20, 2018 |